EyePoint Pharmaceuticals Inc’s recent filing unveils that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May 19 ’25. In the deal valued at $5.99 per share,5,000 shares were bought. As a result of this transaction, Zaderej Karen L. now holds 36,500 shares worth roughly $0.33 million.
Then, Zaderej Karen L. bought 5,000 shares, generating $29,050 in total proceeds. Upon buying the shares at $5.81, the Director now owns 31,500 shares.
Before that, Zaderej Karen L. bought 5,000 shares. EyePoint Pharmaceuticals Inc shares valued at $27,350 were divested by the Director at a price of $5.47 per share. As a result of the transaction, Zaderej Karen L. now holds 26,500 shares, worth roughly $0.24 million.
Citigroup initiated its EyePoint Pharmaceuticals Inc [EYPT] rating to a Buy in a research note published on January 07, 2025; the price target was $33. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid October with a ‘”a Sector outperform”‘ rating. Jefferies began covering EYPT with “Buy” recommendation on August 28, 2024. JP Morgan started covering the stock on January 22, 2024. It rated EYPT as “an Overweight”.
Price Performance Review of EYPT
On Friday, EyePoint Pharmaceuticals Inc [NASDAQ:EYPT] saw its stock jump 1.92% to $9.03. Over the last five days, the stock has gained 1.01%. EyePoint Pharmaceuticals Inc shares have risen nearly 21.21% since the year began. Nevertheless, the stocks have fallen -4.14% over the past one year. While a 52-week high of $13.98 was reached on 06/10/25, a 52-week low of $3.91 was recorded on 04/09/25.
Levels Of Support And Resistance For EYPT Stock
The 24-hour chart illustrates a support level at 8.67, which if violated will result in even more drops to 8.32. On the upside, there is a resistance level at 9.21. A further resistance level may holdings at 9.40.
How much short interest is there in EyePoint Pharmaceuticals Inc?
A steep rise in short interest was recorded in EyePoint Pharmaceuticals Inc stocks on 2025-05-30, dropping by -2.9 million shares to a total of 7.17 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 10.07 million shares. There was a decline of -40.5%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 02, 2023 when Mizuho began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.
